Molecular mechanisms of apoptosis and roles in cancer development and treatment
Programmed cell death (PCD) or apoptosis is a mechanism which is crucial for all
multicellular organisms to control cell proliferation and maintain tissue homeostasis as well …
multicellular organisms to control cell proliferation and maintain tissue homeostasis as well …
Death receptors as targets in cancer
Anti‐tumour therapies based on the use pro‐apoptotic receptor agonists, including TNF‐
related apoptosis‐inducing ligand (TRAIL) or monoclonal antibodies targeting TRAIL‐R1 or …
related apoptosis‐inducing ligand (TRAIL) or monoclonal antibodies targeting TRAIL‐R1 or …
Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells
A Tiptiri-Kourpeti, K Spyridopoulou, V Santarmaki… - PloS one, 2016 - journals.plos.org
Probiotic microorganisms such as lactic acid bacteria (LAB) exert a number of strain-specific
health-promoting activities attributed to their immunomodulatory, anti-inflammatory and anti …
health-promoting activities attributed to their immunomodulatory, anti-inflammatory and anti …
RG7386, a novel tetravalent FAP-DR5 antibody, effectively triggers FAP-dependent, avidity-driven DR5 hyperclustering and tumor cell apoptosis
P Brünker, K Wartha, T Friess, S Grau-Richards… - Molecular cancer …, 2016 - AACR
Dysregulated cellular apoptosis and resistance to cell death are hallmarks of neoplastic
initiation and disease progression. Therefore, the development of agents that overcome …
initiation and disease progression. Therefore, the development of agents that overcome …
Novel apoptosis-inducing agents for the treatment of cancer, a new arsenal in the toolbox
B Lim, Y Greer, S Lipkowitz, N Takebe - Cancers, 2019 - mdpi.com
Evasion from apoptosis is an important hallmark of cancer cells. Alterations of apoptosis
pathways are especially critical as they confer resistance to conventional anti-cancer …
pathways are especially critical as they confer resistance to conventional anti-cancer …
Targeting the anti-apoptotic protein c-FLIP for cancer therapy
AR Safa, KE Pollok - Cancers, 2011 - mdpi.com
Cellular FLICE (FADD-like IL-1beta-converting enzyme)-inhibitory protein (c-FLIP) is a major
resistance factor and critical anti-apoptotic regulator that inhibits tumor necrosis factor-alpha …
resistance factor and critical anti-apoptotic regulator that inhibits tumor necrosis factor-alpha …
Targeting c-FLIP in cancer
S Shirley, O Micheau - Cancer letters, 2013 - Elsevier
Cellular-FLICE inhibitory protein (c-FLIP) is a key anti-apoptotic regulator that inhibits cell
death mediated by the death receptors Fas, DR4, DR5, and TNF-R1. Three splice variants of …
death mediated by the death receptors Fas, DR4, DR5, and TNF-R1. Three splice variants of …
Probiotic potential and biofilm inhibitory activity of Lactobacillus casei group strains isolated from infant feces
Probiotic bacteria are receiving growing interest, particularly for the preparation of functional
foods. In the present study, eight Lactobacillus strains, newly isolated from infant feces, were …
foods. In the present study, eight Lactobacillus strains, newly isolated from infant feces, were …
Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy
AR Safa, TW Day, CH Wu - Current cancer drug targets, 2008 - ingentaconnect.com
Cellular FLICE-like inhibitory protein (c-FLIP) has been identified as a protease-dead,
procaspase-8-like regulator of death ligand-induced apoptosis, based on observations that c …
procaspase-8-like regulator of death ligand-induced apoptosis, based on observations that c …
Drug resistance, predictive markers and pharmacogenomics in colorectal cancer
DB Longley, WL Allen, PG Johnston - … et Biophysica Acta (BBA)-Reviews on …, 2006 - Elsevier
Resistance to chemotherapy limits the effectiveness of current cancer therapies, including
those used to treat colorectal cancer, which is the second most common cause of cancer …
those used to treat colorectal cancer, which is the second most common cause of cancer …